iPROOF will help bioproduct innovators bridge the gap between lab-based innovations and viable commercialization beginning in early 2027.
Public source
Publisher name
Public post
Beginning in early 2027, iPROOF will help bioproduct innovators bridge the gap between lab-based innovations and viable commercialization. Learn more and make your proje…
Company
iPROOF
Accelerating the U.S. bioeconomy
- Industry
- Biotechnology Research
- Location
- Decatur, US
- Company size
- 1 employee
About iPROOF
A flexible, purpose-built, demo-scale fermentation development facility supporting up-to-10,000-liters in the U.S. Midwest. Bioproduct innovators often struggle to find the precision-fermentation development and scale-up services they need to succeed in the fast-moving U.S. market. Moving from pilot-scale to commercial-ready technology requires specialized capabilities that iPROOF will provide starting in 2027 at our new, independent Decatur, IL, facility on the Primient campus.
See moreDiscover more
Similar signals
Similar public activity from other companies.
Partnerships
Manus
Manus announced the construction of its Augusta BioFacility in partnership with HHS Administration for Strategic Preparedness and Response's Industrial Base Management and Supply Chain Office (IBMSC) under the Defense Production Act Title III program.
Partnerships
BioMADE
BioMADE is advancing more accessible, reproducible, and decentralized bioproduction through a new BioMADE project with Roke Biotechnologies and Duke University.
Partnerships
Ennolys by Lesaffre
Ennolys by Lesaffre is expanding its dedicated CDMO services to become a strategic partner in de-risking and accelerating sustainable biotech innovation.
Partnerships
Earthia Bio
Earthia Bio selected County of Los Angeles Department of Public Works among the FY26 selections for the U.S. Department of Energy’s Waste to Energy and Materials Technical Assistance program implemented with the National Laboratory of the Rockies.
Partnerships
Portal Innovations